💉 Bortenat 2 mg Injection | Bortezomib | Multiple Myeloma Treatment | Export Supplier
Bortenat 2 mg Injection contains Bortezomib, a targeted anticancer medicine used in the treatment of multiple myeloma and mantle cell lymphoma. It works by inhibiting proteasomes, leading to cancer cell death and improved disease control.
🔹 Product Category
Oncology Medicine (Targeted Therapy / Proteasome Inhibitor)
🔹 Composition
Bortezomib 2 mg
🔹 Indications
✔ Multiple Myeloma
✔ Mantle Cell Lymphoma
🔹 Key Benefits
✔ Targeted cancer therapy
✔ Effective in relapsed and advanced cases
✔ Improves treatment outcomes in hematologic cancers
✔ Widely used in oncology protocols
🔹 Dosage & Administration
✔ Administered via intravenous or subcutaneous route
✔ Given under strict medical supervision
✔ Dosage based on treatment protocol
🔹 Packaging
✔ Vial Packaging
✔ Export-Ready Packaging Available
✔ Bulk Supply Supported
✔ Private Labeling Available
🔹 Certifications
✔ WHO-GMP Certified
✔ COA & COPP Available
🌍 Target Export Markets & Cities
🇺🇸 USA: New York, Chicago, Houston
🇬🇧 UK: London, Manchester
🇦🇪 UAE: Dubai, Abu Dhabi
🇸🇬 Singapore: Singapore
🇮🇳 India: Mumbai, Delhi, Bangalore
🇵🇭 Philippines: Manila
🇻🇳 Vietnam: Ho Chi Minh City, Hanoi
🇿🇦 South Africa: Johannesburg, Cape Town
🇳🇬 Nigeria: Lagos, Abuja
🇰🇪 Kenya: Nairobi
🇧🇷 Brazil: São Paulo
🇲🇽 Mexico: Mexico City
🇵🇪 Peru: Lima
📍 Location: Nagpur, Maharashtra, India
📦 Product Catalogue Available
✔ Oncology Medicines
✔ HIV & Antiviral Medicines
✔ Specialty Pharmaceutical Products
📞 Instant Support – Call / WhatsApp Now
💬 Quick replies for urgent orders & inquiries!
🌐 Visit Our Official Websites
📧 Business Enquiries & Bulk Orders
🔖 Trending Hashtags
#Oncology #Bortezomib #MultipleMyeloma #CancerTreatment #TargetedTherapy #PharmaExport #GlobalPharma #HospitalSupply #Pharmaceuticals #HealthcareIndustry #MedicineSupplier #B2BPharma #GenericMedicines #InternationalTrade #IndiaPharma #NagpurBusiness #OncologyMedicines
 Injection In USA, UK, Canada Australia, UAE, Saudi Arabia South Africa){kind=link}